Dr. Rhonda W. Gentry, MD
- Medicare services, 2024
- 40,721
- Medicare patients, 2024
- 906
- Part D claims, 2024
- 3,606
- Publications
- 1
- Clinical trials
- 2
- Practice address
- 8901 Carti Way, Little Rock, AR 72205
- Practice phone
- Call (501) 906-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Central Arkansas Radiation Therapy Institute Inc
Little Rock, Arkansas
Find Dr. Gentry's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rhonda W. Gentry is a hematologist and oncologist in Little Rock, Arkansas
Dr. Gentry practices at Central Arkansas Radiation Therapy Institute Inc in Little Rock, Arkansas.
Dr. Gentry's NPI, 1891834016, was assigned on February 5, 2007. Dr. Gentry graduated from University of Arkansas College of Medicine in 2002. Dr. Gentry holds Arkansas license E-4524.
- NPI
- 1891834016NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1456423870
- NPI enumeration date
- February 5, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (501) 906-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rhonda W. Gentry practices at Central Arkansas Radiation Therapy Institute Inc in Little Rock, Arkansas
Dr. Gentry's primary practice is Central Arkansas Radiation Therapy Institute Inc, at 8901 Carti Way, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 906-3000.
- Central Arkansas Radiation Therapy Institute Inc8901 Carti Way, Little Rock, AR 72205 · Pulaski CountyPhone(501) 906-3000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Rhonda W. Gentry is affiliated with 4 sites of care and 1 medical group
Dr. Gentry's primary practice is Central Arkansas Radiation Therapy Institute Inc in Little Rock, Arkansas. Dr. Gentry is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is CARTI. Dmand AI also links Dr. Gentry to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Rhonda W. Gentry's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gentry practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Central Arkansas Radiation Therapy Institute Inc | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rhonda W. Gentry is one of 89 hematologists and oncologists in Arkansas
Hematology and oncology is Dr. Gentry's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gentry is licensed in Arkansas.
Specialties and state licenses
- Hematology and oncology, ArkansasPrimary
Hematologists and oncologists near Dr. Gentry
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rhonda W. Gentry billed Medicare for 40,721 services in 2024
CMS data shows 40,721 Medicare services from Dr. Gentry across 69 procedure codes in 2024, for 906 Medicare patients. Medicare paid $913,188 for them.
Dr. Gentry's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 29,9112024: 23,27122%
- Lab and pathology
- 2023: 11,5182024: 11,483No change
- Surgery
- 2023: 2,4972024: 2,3247%
- Office and hospital visits
- 2023: 2,2732024: 2,2451%
- Tests and treatments
- 2023: 1,7492024: 1,37921%
- Other services
- 2023: 162024: 1919%
Where Dr. Gentry's Medicare services took place, 2024
- In an office40,39499%
- In a facility3271%
Dr. Gentry compared with the Arkansas median for hematologists and oncologists, 2024
- Dr. Gentry
- Arkansas median
- Medicare services
- 40,721vs 4,8168.5 times
- Medicare patients
- 906vs 75820% above
- Part D claims
- 3,303vs 1,1732.8 times
Medians across 88 hematologists and oncologists in Arkansas with Dmand AI profiles that report each measure.
Dr. Gentry's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gentry?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gentry and other hematologists and oncologists in Arkansas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rhonda W. Gentry treated 906 Medicare patients in 2024, average age 74
CMS counts 906 Medicare patients who saw Dr. Gentry in 2024. The largest group is 65 to 74, with 413 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Gentry's median patient age at 68, with 72% women.
Dr. Gentry's Medicare patients by age, 2024
Dr. Gentry's Medicare patients by sex, 2024
- Women64171%
- Men26529%
Chronic conditions among Dr. Gentry's Medicare patients, 2024
- High blood pressure75%
- High cholesterol71%
- Cancer61%
- Arthritis49%
- Ischemic heart disease39%
- Diabetes34%
- Mood disorders32%
- Anxiety31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gentry's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women72%
- Men28%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rhonda W. Gentry wrote 3,606 Medicare Part D claims in 2024
In 2024, Dr. Gentry wrote 3,606 Medicare Part D claims for 432 patients. 79% of them were for generic drugs. CMS names the drug for 3,303 of them, across 61 drugs with 11 or more claims each, at $4,336,257 in total drug cost. In 2023, CMS named 2,880 claims across 53 drugs.
Dr. Gentry's Part D claims by kind of drug, 2024
- Generic2,853 claims79%
- Brand-name734 claims20%
- Other19 claims1%
Dr. Gentry's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gentry's Part D claims, 2024
- Opioids3%104 of 3,606 claims
- Antibiotics1%42 of 3,606 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,8802024: 3,30315%
Drugs named by CMS: 61 in 2024, 53 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rhonda W. Gentry scored 89 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gentry for performance year 2024, reported as part of a group. Dr. Gentry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Gentry's MIPS scores, performance year 2024
- 89of 100Final score
- 90.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rhonda W. Gentry has 1 publication on record
Dmand AI links 1 paper to Dr. Gentry in 2016. Dr. Gentry's most frequent co-authors are Varinder Kaur, MD, Srikanth Medarametla, MD and Eric Siegel, MD.
Dr. Gentry's most frequent co-authors
Recent publications by Dr. Gentry
See who Dr. Gentry researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gentry works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rhonda W. Gentry has worked on 2 clinical trials
Dmand AI links Dr. Gentry to 2 clinical trials. Conditions studied include Carcinoid Tumor and Neuroendocrine Tumors.
Clinical trials with Dr. Gentry by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- 1Phase 4: 1 trial
Conditions in Dr. Gentry's trials
- Carcinoid Tumor
- Neuroendocrine Tumors
Investigators on the most trials with Dr. Gentry
- Brad Patrick Baltz, MD1 shared trial
- Pradeep G. Bhambhvani, MD1 shared trial
- David L. Bushnell, MD1 shared trial
Recent clinical trials with Dr. Gentry
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Rhonda W. Gentry received $5,355 in industry payments from 2016 to 2025
CMS Open Payments shows 114 general payments to Dr. Gentry from 31 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 56% of the total. Sirtex Medical Inc paid the most, $3,402. It also lists 55 research payments totaling $6,597 from 2020 to 2023.
General payments to Dr. Gentry by program year, 2016 to 2025
General payments to Dr. Gentry by kind, 2016 to 2025
- Honoraria$3,00056%
- Food and beverage$1,89735%
- Education$4589%
Companies that paid Dr. Gentry the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Rhonda W. Gentry graduated from University of Arkansas College of Medicine
Dr. Gentry graduated from University of Arkansas College of Medicine in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Rhonda W. Gentry's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rhonda W. Gentry
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rhonda W. Gentry's NPI number?
Dr. Rhonda W. Gentry's NPI number is 1891834016. It was assigned on February 5, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Rhonda W. Gentry?
Dr. Rhonda W. Gentry is a hematologist and oncologist in Little Rock, Arkansas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Rhonda W. Gentry practice?
Dr. Gentry practices at 8901 Carti Way, Little Rock, AR 72205. Dr. Gentry's primary practice is Central Arkansas Radiation Therapy Institute Inc in Little Rock, Arkansas. Dmand AI also links Dr. Gentry to 1 hospital and 1 group practice or clinic.
What is Dr. Rhonda W. Gentry's office phone number?
The practice phone on file for Dr. Gentry is (501) 906-3000.
What is Dr. Rhonda W. Gentry's medical license number?
Dr. Gentry holds Arkansas license E-4524.
Which hospitals is Dr. Rhonda W. Gentry affiliated with?
Dr. Gentry is affiliated with Baptist Health Medical Center-Little Rock. Dmand AI links Dr. Gentry to 1 more hospital.
What medical group is Dr. Rhonda W. Gentry part of?
Dr. Gentry is linked to CARTI.
Does Dr. Rhonda W. Gentry accept Medicare?
Yes. CMS data shows Dr. Gentry billed Medicare for 40,721 services in 2024, and Dr. Gentry accepts Medicare assignment.
What is Dr. Rhonda W. Gentry's MIPS score?
Dr. Gentry's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.
How many Medicare patients does Dr. Rhonda W. Gentry see?
CMS counts 906 Medicare patients who saw Dr. Gentry in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Rhonda W. Gentry bill to Medicare?
In 2024, Dr. Gentry's most billed Medicare services were injected or infused drug (J9299), injected or infused drug (J0897) and injected or infused drug (J9271).
Where did Dr. Rhonda W. Gentry go to medical school?
Dr. Gentry graduated from University of Arkansas College of Medicine in 2002.
What drugs does Dr. Rhonda W. Gentry prescribe most?
In 2024 Medicare Part D data, Dr. Gentry's most prescribed drugs by claims were Anastrozole, Omeprazole and Letrozole.
Has Dr. Rhonda W. Gentry received payments from drug or device companies?
CMS Open Payments shows $5,355 in general payments to Dr. Gentry from 31 companies from 2016 to 2025. The largest total came from Sirtex Medical Inc.
How long has Dr. Rhonda W. Gentry been practicing?
Dr. Gentry graduated from medical school in 2002, 24 years ago.
Does Dr. Rhonda W. Gentry do research?
Dmand AI links 1 publication to Dr. Gentry. Dr. Gentry has worked on 2 clinical trials.
Who does Dr. Rhonda W. Gentry publish with?
Dr. Gentry's most frequent co-authors are Varinder Kaur, MD (1 shared paper), Srikanth Medarametla, MD (1 shared paper) and Eric Siegel, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Arkansas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card